Transdermal Drug Delivery System Market is anticipated to reach USD 81.4 billion by 2024 owing to shift toward sedentary lifestyle that encourages chronic disorders. Transdermal drug delivery is a painless process of delivering drug in the body part. TDDS delivers drug through the skin in pre-decided and regulated rate. It offers extended therapeutic effects, lesser side-effects, improved patient compliance, better bioavailability, and easy cessation of drug treatment. Transdermal drug delivery is much preferred today as compared to the conventional oral method or injectables.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/transdermal-drug-delivery-system-market/request-sample
The key driving factors responsible for the growth of Transdermal
Drug Delivery System market :
Transdermal drug delivery systems
market is witnessing growth due to the factors like increasing consumer
preference for minimally invasive procedures for chronic disorders and multiple
advantages associated with TDDS. Infusion of drug could be effectively
monitored and projected creditably through transdermal drug delivery method,
which makes it convenient to maintain steady level of drug. However,
transdermal drug delivery system industry is restrained by constrained areas of
delivery and slow infusion rate hydrophilic drugs.
Recent years has introduced
multiple drugs that could be delivered through transdermal route. Also, the
existing market players in this market are focusing on mergers and acquisition
to create niche market.Transdermal drug delivery system market is categorized
on the basis of delivery system type, application, and geography. On the basis
of delivery system type, the market is divided into active (matrix system,
reservoir system), passive (electrical based, structure based) and others.
Electrical based systems can be further classified as iontophoresis, electroporation
and sonophoresis. Passive delivery system segment is predicted to lead the
market of transdermal drug delivery system due to rise in chronic disorders.
Based on application, transdermal
drug delivery systems industry is divided into analgesics, hormone replacement
therapy, motion sickness, cardiovascular disorder, smoking cessation, and
others. Cardiovascular disorder segment is projected to hold larger market
share of transdermal drug delivery system owing to the increase in cases of
heart-related disorders.
Geographically, transdermal drug
delivery systems market is segmented as North America, Latin America, Europe,
Asia Pacific and Middle East & Africa. Asia Pacific is expected to dominate
transdermal drug delivery system industry owing to the growing number of
patients suffering from chronic disorders. The prominent players in transdermal
drug delivery systems industry include Acrux Limited, Echo Therapeutics, Inc.,
Johnson & Johnson, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Boehringer
Ingelheim GmbH, Mylan N.V., Bayer AG, Endo Pharmaceuticals Inc. and Novartis
AG.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/transdermal-drug-delivery-system-market
No comments:
Post a Comment